Literature DB >> 9146010

Intravesical dimethyl sulfoxide (DMSO) for interstitial cystitis--a practical approach.

J Parkin1, C Shea, G R Sant.   

Abstract

OBJECTIVES: To provide a brief overview of intravesical dimethly sulfoxide (DMSO) therapy for interstitial cystitis and offer a practical approach to patient treatment.
METHODS: A review of the literature and a summation of the experience with treatment of > 300 patients with DMSO at the Interstitial Cystitis Clinic, New England Medical Center.
RESULTS: DMSO is helpful in a significant number of patients and it has acceptable morbidity and an excellent safety profile.
CONCLUSIONS: Intravesical DMSO (singly or in combination) is one of the mainstays in the pharmacologic treatment of interstitial cystitis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9146010     DOI: 10.1016/s0090-4295(97)00181-7

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  26 in total

Review 1.  Advances in intravesical therapy for urinary tract disorders.

Authors:  Pradeep Tyagi; Mahendra Kashyap; Harvey Hensley; Naoki Yoshimura
Journal:  Expert Opin Drug Deliv       Date:  2015-10-19       Impact factor: 6.648

Review 2.  Recent advances in intravesical drug/gene delivery.

Authors:  Pradeep Tyagi; Pao-Chu Wu; Michael Chancellor; Naoki Yoshimura; Leaf Huang
Journal:  Mol Pharm       Date:  2006 Jul-Aug       Impact factor: 4.939

3.  Oral dimethyl sulfoxide for systemic amyloid A amyloidosis complication in chronic inflammatory disease: a retrospective patient chart review.

Authors:  Sadahiro Amemori; Ryuichi Iwakiri; Hiroyoshi Endo; Akifumi Ootani; Shinichi Ogata; Takahiro Noda; Seiji Tsunada; Hiroyuki Sakata; Hisashi Matsunaga; Masanobu Mizuguchi; Yuji Ikeda; Kazuma Fujimoto
Journal:  J Gastroenterol       Date:  2006-05       Impact factor: 7.527

4.  Risk factors that affect the treatment of interstitial cystitis using intravesical therapy with a dimethyl sulfoxide cocktail.

Authors:  Man-Jung Hung; Yi-Ting Chen; Pao-Sheng Shen; Shih-Tien Hsu; Gin-Den Chen; Esther Shih-Chu Ho
Journal:  Int Urogynecol J       Date:  2012-03-17       Impact factor: 2.894

5.  Dimethyl sulfoxide inhibits zymosan-induced intestinal inflammation and barrier dysfunction.

Authors:  Yu-Meng Li; Hai-Bin Wang; Jin-Guang Zheng; Xiao-Dong Bai; Zeng-Kai Zhao; Jing-Yuan Li; Sen Hu
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

6.  Long-term outcomes of intravesical dimethyl sulfoxide/heparin/hydrocortisone therapy for interstitial cystitis/bladder pain syndrome.

Authors:  Yik N Lim; Peter Dwyer; Christine Murray; Debjyoti Karmakar; Anna Rosamilia; Elizabeth Thomas
Journal:  Int Urogynecol J       Date:  2016-12-16       Impact factor: 2.894

7.  CUA guideline: Diagnosis and treatment of interstitial cystitis/bladder pain syndrome.

Authors:  Ashley Cox; Nicole Golda; Genevieve Nadeau; J Curtis Nickel; Lesley Carr; Jacques Corcos; Joel Teichman
Journal:  Can Urol Assoc J       Date:  2016-05-12       Impact factor: 1.862

Review 8.  Tumour suppressor HLJ1: A potential diagnostic, preventive and therapeutic target in non-small cell lung cancer.

Authors:  Meng-Feng Tsai; Chi-Chung Wang; Jeremy Jw Chen
Journal:  World J Clin Oncol       Date:  2014-12-10

9.  Intravesical dimethyl sulfoxide inhibits acute and chronic bladder inflammation in transgenic experimental autoimmune cystitis models.

Authors:  Ronald Kim; Wujiang Liu; Xiaohong Chen; Karl J Kreder; Yi Luo
Journal:  J Biomed Biotechnol       Date:  2010-11-11

Review 10.  Paediatric painful bladder syndrome/interstitial cystitis: diagnosis and treatment.

Authors:  Jason Sea; Joel M H Teichman
Journal:  Drugs       Date:  2009       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.